nylidrin has been researched along with Clerambault Syndrome in 1 studies
Nylidrin: A beta-adrenergic agonist. Nylidrin causes peripheral vasodilation, a positive inotropic effect, and increased gastric volume of gastric juice. It is used in the treatment of peripheral vascular disorders and premature labor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goldstein, SE | 1 |
| Birnbom, F | 1 |
1 trial available for nylidrin and Clerambault Syndrome
| Article | Year |
|---|---|
Nylidrin HCL in the treatment of symptoms of the aged: a double-blind placebo controlled study.
Topics: Activities of Daily Living; Aged; Depression; Double-Blind Method; Drug Evaluation; Female; Humans; | 1979 |